Healthcare provider profile · identity verified

Hope Easler Lipscomb, NP

Nurse Practitioner · COLUMBIA, SC · NPI 1255848032

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	179	33
Atorvastatin Calcium	Atorvastatin Calcium	167	39
Amlodipine Besylate	Amlodipine Besylate	131	27
Gabapentin	Gabapentin	120	23
Escitalopram Oxalate	Escitalopram Oxalate	108	17
Pantoprazole Sodium	Pantoprazole Sodium	97	23
Trazodone Hcl	Trazodone Hcl	97	18
Lisinopril	Lisinopril	88	20
Eliquis	Apixaban	87	12
Potassium Chloride	Potassium Chloride	83	17
Sertraline Hcl	Sertraline Hcl	81	14
Metoprolol Succinate	Metoprolol Succinate	79	16
Hydrochlorothiazide	Hydrochlorothiazide	75	14
Metoprolol Tartrate	Metoprolol Tartrate	75	suppressed
Donepezil Hcl	Donepezil Hcl	73	11
Losartan Potassium	Losartan Potassium	73	15
Furosemide	Furosemide	70	14
Omeprazole	Omeprazole	68	17
Quetiapine Fumarate	Quetiapine Fumarate	61	12
Citalopram Hbr	Citalopram Hydrobromide	60	suppressed
Metformin Hcl	Metformin Hcl	51	suppressed
Montelukast Sodium	Montelukast Sodium	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	15
Lorazepam	Lorazepam	43	14
Tamsulosin Hcl	Tamsulosin Hcl	43	suppressed
Carvedilol	Carvedilol	42	12
Memantine Hcl	Memantine Hcl	42	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	11
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Nifedipine Er	Nifedipine	39	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Famotidine	Famotidine	33	suppressed
Clonazepam	Clonazepam	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	12
Colestipol Hcl	Colestipol Hcl	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Simvastatin	Simvastatin	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	16
Aripiprazole	Aripiprazole	20	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Methylprednisolone	Methylprednisolone	18	17
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Temazepam	Temazepam	16	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Risperidone	Risperidone	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Azithromycin	Azithromycin	12	11
Bupropion Hcl	Bupropion Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Digoxin	Digoxin	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error